The Motley Fool··Eric VolkmanBoston Scientific Poised for 5X Growth as Aging Demographics Drive Demand
Boston Scientific positioned to capitalize on global aging through AFib, chronic pain, and Parkinson's treatments; recent acquisitions boost stroke capabilities.
BSXPENhealthcarevaluation